Chairman of the Board, Dr. Peter Schiemann, will participate at JPMorganBIO in San Francisco 12.-16. January
top of page
Search
Recent Posts
See AllPrinceton, NJ, December 14, 2022 ─ iQure Pharma Inc. (iQure), a US-based global biotech company, is attending the 41st Annual J.P. Morgan Health Care Conference, JPM Week, in January 2023. iQure’s por
24
iQure Pharma is one of 25 companies invited to join the NYU Stern School of Business Endless Frontier Labs 2022-2023 cohort dedicated to companies developing treatments that address unmet health needs
17
Keiretsu Forum and Business Angel Investors Provide Funding to Support Research into Neuropathic Pain Compounds iQ-007 and iQ-008 Princeton, NJ, August 31, 2022 ─ iQure Pharma Inc. (iQure), a Princeto
123
bottom of page